Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9K Sell
100
-91
-48% -$11K ﹤0.01% 2056
2026
Q2
$25.5K Hold
191
– – ﹤0.01% 1697
2026
Q1
$21.3K Buy
+191
New +$22.6K ﹤0.01% 1648

Other funds holding ABVX

CoreCap Advisors's ABVX Position: Q3 2026 in Review

CoreCap Advisors reduced its Abivax (ABVX) stake by 48% in Q3 2026, selling an estimated $11K and leaving 100 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

CoreCap Advisors first reported a position in ABVX in Q1 2026 and has held it in 3 quarters since. The position peaked at $25.5K in Q2 2026. 9 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • CoreCap Advisors held 100 shares of Abivax worth $9.9K as of Q3 2026.
  • CoreCap Advisors sold 91 Abivax shares in Q3 2026, an estimated $11K.
  • Abivax made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2056 holding.
  • CoreCap Advisors first reported a position in Abivax in Q1 2026 and has held it in 3 quarters since.
  • CoreCap Advisors's Abivax position peaked at $25.5K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.